Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIα subunit

Antisense and Nucleic Acid Drug Development

Volumn 10, Issue 6, 2000, Pages 423-433

  Nesterova, M ^a   Cho Chung, Y S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; PROTEIN SUBUNIT;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; COLON CARCINOMA; COLONY FORMATION; DNA RNA HYBRIDIZATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKEMIA CELL; LUNG CARCINOMA; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SIGNAL TRANSDUCTION; T CELL LYMPHOMA;

MAMMALIA; MUS MUSCULUS;

EID: 0034537149     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.2000.10.423     Document Type: Article

References (52)

1. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies
2. Antisense therapeutics
3. Compensatory regulation of RIα protein levels in protein kinase. A mutant mice
4. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
5. Mechanisms of control for cAMP-dependent protein kinase from skeletal muscle
6. Growth-regulatory effect of gastrin on human colon cancer cell lines is determined by protein kinase A isoform content
7. Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals
8. Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa
9. ® 231) targeting the type I protein kinase A by 2-hour infusions in patients with refractory solid tumors
10. Role of cyclic ANP receptor proteins in growth, differentiation, and suppression of malignancy: New approaches to therapy [Perspectives in cancer research]
11. Comparative studies on cyclic AMP binding and protein kinase in cyclic AMP-responsive and -unresponsive Walker 256 mammary carcinomas
12. Antisense-protein kinase A: A single-gene-based therapeutic approach
13. m cyclic AMP phosphodiesterases: A family of highly related enzymes
14. The distribution and dissociation of cyclic adenosine 3′,5′-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues
15. Therapeutic applications of oligonucleotides
16. Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase
17. Radioimmunoassay of bovine heart protein kinase
18. Nerve growth factor activates a ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB
19. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence
20. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue
21. Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors
22. Concentrations of cyclic AMP-dependent protein kinase subunits in various tissues
23. CpG motifs in bacterial DNA trigger direct B-cell activation
24. Protein measurement with the Folin phenol reagent
25. Cyclic GMP-inhibited cyclic nucleotide phosphodiesterases
26. Increased expression of the RIα subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer
27. Study of antisense oligonucleotide phosphorothioates containing segments of oligonucleoxynucleotides and 2′O′methyloligoribonucleotides
28. Changes in messenger RNA expression of protein kinase A regulatory subunit ialpha in breast cancer patients treated with tamoxifen
29. Types of cyclic AMP binding proteins in human breast cancers
30. Tumor cyclic AMP binding proteins: An independent prognostic factor for disease recurrence and survival in breast cancer
31. Antitumor activity of a phospborothioate antisense oligonucleotide targeted against c-raf kinase
32. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene
33. Differential expression of cGMP-inhibited cyclic nucleotide phosphodiesterases in human hepatoma cell lines
34. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type I replication and cytokine production in primary T cells: Involvement of NF-κB and NFAT
35. A single-injection protein kinase A-directed antisense treatment to inhibit tumor growth
36. Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta
37. A cyclic adenosine 3′-5′-monophosphate-dependent histone kinase from pig brain. Purification and some properties of the enzyme
38. Regulation of multidrug resistance through the cAMP and EGF signalling pathways
39. Properties of the cyclid AMP-dependent protein kinase from bovine and porcine heart
40. Type I cyclic AMP-dependent protein kinase as a positive effector of growth
41. Cyclic adenosine 3′,5′-monophosphate-binding proteins in human ovarian cancer: Correlations with clinicopathological features
42. cAMP-dependent protein kinase: Prototype for a family of enzymes
43. An antisense oligodeoxynucleotide targeted against the type IIβ regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects
44. The RIα subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF receptor
45. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide Of cAMP-dependent protein kinase
46. Self-phosphorylation of cAMP-dependent protein kinase from porcine brain
47. Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIα sub-unit of protein kinase A after oral administration
48. Novel function of the regulatory subunit of protein kinase A: Regulation of cytochrome coxidase activity and cytochrome c release
49. 8-Chloroadenosine 3′,5′-monophosphate as a novel modulator of multidrug resistance
50. An antisense oligodeoxynucleotide that depletes RIα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells
51. Regulation of Lewis lung carcinoma invasion and metastasis by protein kinase A
52. Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity